Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP757113.RAoXS2ycX-twUn57NT7WNsvQrIXWkNjX9N13hpz-8vf7c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP757113.RAoXS2ycX-twUn57NT7WNsvQrIXWkNjX9N13hpz-8vf7c130_assertion type Assertion NP757113.RAoXS2ycX-twUn57NT7WNsvQrIXWkNjX9N13hpz-8vf7c130_head.
- NP757113.RAoXS2ycX-twUn57NT7WNsvQrIXWkNjX9N13hpz-8vf7c130_assertion wasGeneratedBy ECO_0000203 NP757113.RAoXS2ycX-twUn57NT7WNsvQrIXWkNjX9N13hpz-8vf7c130_provenance.
- NP757113.RAoXS2ycX-twUn57NT7WNsvQrIXWkNjX9N13hpz-8vf7c130_assertion wasDerivedFrom befree-2016 NP757113.RAoXS2ycX-twUn57NT7WNsvQrIXWkNjX9N13hpz-8vf7c130_provenance.
- NP757113.RAoXS2ycX-twUn57NT7WNsvQrIXWkNjX9N13hpz-8vf7c130_assertion SIO_000772 19673887 NP757113.RAoXS2ycX-twUn57NT7WNsvQrIXWkNjX9N13hpz-8vf7c130_provenance.
- NP757113.RAoXS2ycX-twUn57NT7WNsvQrIXWkNjX9N13hpz-8vf7c130_assertion evidence source_evidence_literature NP757113.RAoXS2ycX-twUn57NT7WNsvQrIXWkNjX9N13hpz-8vf7c130_provenance.
- NP757113.RAoXS2ycX-twUn57NT7WNsvQrIXWkNjX9N13hpz-8vf7c130_assertion description "[Oral administration of gefitinib significantly (P < 0.001) reduced tumor growth of xenografts of three HNSCC cell lines (HSC-2, HSC-3, and HSC-4), in female athymic nude mice, accompanied by an increase in BRAK expression specifically in tumor tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP757113.RAoXS2ycX-twUn57NT7WNsvQrIXWkNjX9N13hpz-8vf7c130_provenance.